Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Blinding01:11

Blinding

2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graph Based, Adaptive, Multiarm, Multiple Endpoint, Two-Stage Designs.

Statistics in medicine·2025
Same author

Peroneal Nerve Palsy After a Minimally Displaced Weber B Fibula Fracture: A Rare Case of Extensor Retinaculum Syndrome.

Foot & ankle orthopaedics·2025
Same author

A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design.

Statistics in medicine·2025
Same author

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials.

JAMA network open·2022
Same author

Optimal adaptive promising zone designs.

Statistics in medicine·2022
Same author

A simulation-based comparison of estimation methods for adaptive and classical group sequential clinical trials.

Pharmaceutical statistics·2021
Same journal

Public Health Response to Clade Ib Mpox with Multiple Exposures in Congregate Living Settings - New Hampshire, February 2025.

NEJM evidence·2026
Same journal

Berberine-Ursodeoxycholate - Bringing Traditional Chinese Medicine to Our World.

NEJM evidence·2026
Same journal

Outbreak of Legionnaires' Disease Associated with Cooling Tower Systems in Central Harlem.

NEJM evidence·2026
Same journal

Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency.

NEJM evidence·2026
Same journal

A Randomized Trial of Interval Likelihood Ratios for Clinical Decision-Making.

NEJM evidence·2026
Same journal

Evidence for Evidence-Based Medicine - A Call for Some Theory and a New Problem.

NEJM evidence·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Power Considerations in Designing and Interpreting Adaptive Clinical Trials.

Rui Wang1,2, Cyrus Mehta2,3

  • 1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston.

NEJM Evidence
|February 6, 2024
PubMed
Summary
This summary is machine-generated.

Adaptive clinical trials enable real-time study modifications. The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial evaluated apixaban versus aspirin in patients with cardioembolism risk factors.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K

Related Experiment Videos

Last Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K

Area of Science:

  • Clinical Trials
  • Cardiovascular Research
  • Neurology

Background:

  • Adaptive clinical trials offer flexibility in study design by allowing pre-planned modifications based on interim data.
  • These modifications can optimize trial efficiency and validity, including sample size adjustments and treatment alterations.
  • The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial investigated apixaban against aspirin in patients with cardioembolism risk factors.

Discussion:

  • The ATTICUS trial's adaptive design allowed for data-driven adjustments, potentially enhancing the precision and relevance of the findings.
  • Evaluating novel anticoagulants like apixaban is crucial for managing stroke risk in patients with cardioembolic sources.
  • Comparing apixaban with aspirin provides insights into optimal secondary stroke prevention strategies.

Key Insights:

  • The study reports on the comparative efficacy and safety of apixaban versus aspirin in a specific stroke population.
  • Results from the ATTICUS trial contribute to the evidence base for antithrombotic therapy in stroke of undetermined source.
  • Findings may inform clinical guidelines regarding the use of direct oral anticoagulants in secondary stroke prevention.

Outlook:

  • Future research may explore long-term outcomes and cost-effectiveness of apixaban in this patient group.
  • The application of adaptive trial methodologies in cardiovascular research is expected to grow.
  • Continued investigation into personalized antithrombotic strategies based on individual patient risk profiles is warranted.